Stephen Rocamboli Esperion Therapeutics, Inc. (ESPR) insider trading activity

Stephen Rocamboli is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 69,261 shares of ESPR, which is worth approximately $67,875. The most recent transaction as insider was on May 29, 2025, when has been sold 33,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.3K

91.01% 3M change

91.01% 12M change

Total Value Held $67,875

STEPHEN ROCAMBOLI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2025	BUY Grant, award, or other acquisition	-	33,000 Added 32.27%	69,261 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	23,000 Added 38.81%	36,261 Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	5,150 Added 27.97%	13,261 Common Stock
May 10 2023	BUY Open market or private purchase	$12,166 $1.5 p/Share	8,111 Added 50.0%	8,111 Common Stock

Also insider at

TFFP

TFF Pharmaceuticals, Inc. Healthcare

Director